Source:http://linkedlifedata.com/resource/pubmed/id/10629167
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-2-17
|
pubmed:abstractText |
We evaluated the effect of insulin-like growth factor (IGF)-I on neuronal cell viability and apoptosis induced by exposure to serum-free (SF) medium and to doxorubicin. In primary neuronal culture, IGF-I (0.5-2.0 microg/ml) slightly increased basal cell viability; SF medium tended to decrease viability (20-27%), and addition of IGF-I significantly antagonized this decrease (P< 0.05). In neuroblastoma (NB) SK-N-SH cell culture, IGF-I significantly increased viability (0.05-1.25 microg/ml) (P< 0.005); SF medium decreased it by 75%, and this decrease was prevented by IGF-I (0.5-1. 0 microg/ml) (P< 0.005). Flow cytometry studies showed an increased apoptosis on exposure to SF medium (88.8 vs 10.2%), which was suppressed to 38.3% by addition of IGF-I. Growth hormone (1-10 microU/ml) did not modify basal cell viability in either culture, and SF-induced cell death in NB cells. Doxorubicin (1-100 microM) caused neurotoxicity in primary and NB cultures (66-39% and 39-10% of controls, respectively), and increased apoptosis in NB cells (73. 8 vs 20.1%). IGF-I antagonized these neurotoxic/apoptotic effects (P< 0.05). This study suggests that IGF-I possesses a potent neuroprotective activity which may be involved in the resistance to doxorubicin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1096-6374
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1999 Harcourt Publishers Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
458-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10629167-Animals,
pubmed-meshheading:10629167-Apoptosis,
pubmed-meshheading:10629167-Brain,
pubmed-meshheading:10629167-Cell Survival,
pubmed-meshheading:10629167-Cells, Cultured,
pubmed-meshheading:10629167-Culture Media, Serum-Free,
pubmed-meshheading:10629167-Doxorubicin,
pubmed-meshheading:10629167-Flow Cytometry,
pubmed-meshheading:10629167-Growth Hormone,
pubmed-meshheading:10629167-Humans,
pubmed-meshheading:10629167-Insulin-Like Growth Factor I,
pubmed-meshheading:10629167-Mice,
pubmed-meshheading:10629167-Mice, Inbred ICR,
pubmed-meshheading:10629167-Neuroblastoma,
pubmed-meshheading:10629167-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Insulin-like-growth-factor-I (IGF-I) antagonizes apoptosis induced by serum deficiency and doxorubicin in neuronal cell culture.
|
pubmed:affiliation |
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Beilinson Campus Petah-Tiqva, Israel.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|